Ramin Salehi-Rad

Title(s)HS Assistant Clinical Professor, Medicine
SchoolMedicine
ORCID ORCID Icon0000-0003-1543-5421 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Salehi-Rad is a physician scientist engaged in clinical and translational research in lung cancer. Dr. Salehi-Rad’s research primarily focuses on improving our understanding of the tumor microenvironment and mechanisms through which tumors evade host immune responses. Additionally, Dr. Salehi-Rad’s lab is actively exploring the development of novel gene-modified dendritic cell cancer vaccines as a strategy for overcoming resistance to immunotherapy. As a Pulmonologist, Dr. Salehi-Rad specializes in early detection of lung cancer. He is an active participant in the national consortia in lung cancer, including the NCI Human Tumor Atlas Network (HTAN) and Early Detection Research Network (EDRN) as well as the Stand-Up-To-Cancer (SU2C) Lung Cancer Interception Dream Team.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Characteristics of a CCL21-gene modified dendritic cell vaccine utilized for a clinical trial in non-small cell lung cancer. Mol Cancer Ther. 2024 Nov 19. Oh MS, Dumitras C, Salehi-Rad R, Tran LM, Krysan K, Lim RJ, Jing Z, Tappuni S, Lisberg A, Garon EB, Dubinett SM, Liu B. PMID: 39559833.
      View in: PubMed   Mentions:    Fields:    
    2. Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine non-small cell lung cancer. Cancer Immunol Res. 2024 Sep 26. Du Y, Salehi-Rad R, Zhang TH, Crosson WP, Abascal J, Chen D, Shi Y, Jiang H, Tseng YW, Ma X, Hong M, Wang S, Wang X, Tang K, Hu S, Li Y, Ni S, Cai Y, Tappuni S, Shen Y, Liu B, Sun R. PMID: 39325056.
      View in: PubMed   Mentions:    Fields:    
    3. Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):548-571. Moghaddam SJ, Savai R, Salehi-Rad R, Sengupta S, Kammer MN, Massion P, Beane JE, Ostrin EJ, Priolo C, Tennis MA, Stabile LP, Bauer AK, Sears CR, Szabo E, Rivera MP, Powell CA, Kadara H, Jenkins BJ, Dubinett SM, Houghton AM, Kim CF, Keith RL. PMID: 39115548; PMCID: PMC11389570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer. Cell Rep Med. 2024 Apr 16; 5(4):101479. Lim RJ, Salehi-Rad R, Tran LM, Oh MS, Dumitras C, Crosson WP, Li R, Patel TS, Man S, Yean CE, Abascal J, Huang Z, Ong SL, Krysan K, Dubinett SM, Liu B. PMID: 38518770; PMCID: PMC11031384.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    5. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Nat Commun. 2024 Jan 09; 15(1):404. Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman MC, Krammer F, van Bakel H, IMPACC Network, Maecker HT, Rouphael N, Diray-Arce J, Wigdahl B, Kutzler MA, Cairns CB, Haddad EK, Comunale MA. PMID: 38195739; PMCID: PMC10776791.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    6. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study. Nat Commun. 2024 Jan 03; 15(1):216. Ozonoff A, Jayavelu ND, Liu S, Melamed E, Milliren CE, Qi J, Geng LN, McComsey GA, Cairns CB, Baden LR, Schaenman J, Shaw AC, Samaha H, Seyfert-Margolis V, Krammer F, Rosen LB, Steen H, Syphurs C, Dandekar R, Shannon CP, Sekaly RP, Ehrlich LIR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Sesma AF, Simon V, van Bakel H, Kim-Schulze S, Hafler DA, Levy O, Kraft M, Bime C, Haddad EK, Calfee CS, Erle DJ, Langelier CR, Eckalbar W, Bosinger SE, IMPACC Network, Peters B, Kleinstein SH, Reed EF, Augustine AD, Diray-Arce J, Maecker HT, Altman MC, Montgomery RR, Becker PM, Rouphael N. PMID: 38172101; PMCID: PMC10764789.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    7. Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant Recipients. Res Sq. 2023 Dec 20. Langelier C, Pickering H, Schaenman J, Phan H, Maguire C, Tsitsiklis A, Rouphael N, Higuita N, Atkinson M, Breckenridge S, Fung M, Messer W, IMPACC Network, Salehi-Rad R, Altman M, Becker P, Bosinger S, Eckalbar W, Hoch A, Jayavelu N, Kim-Schulze S, Jenkins M, Kleinstein S, Krammer F, Maecker H, Ozonoff A, Diray-Arce J, Shaw A, Baden L, Levy O, Reed E. PMID: 38196658; PMCID: PMC10775393.
      View in: PubMed   Mentions:
    8. Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment. Cells. 2023 10 04; 12(19). Abascal J, Oh MS, Liclican EL, Dubinett SM, Salehi-Rad R, Liu B. PMID: 37830618; PMCID: PMC10571973.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    9. Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma. Cancer Res. 2023 10 02; 83(19):3305-3319. Yanagawa J, Tran LM, Salehi-Rad R, Lim RJ, Dumitras C, Fung E, Wallace WD, Prosper AE, Fishbein G, Shea C, Hong R, Kahangi B, Deng JJ, Gower AC, Liu B, Campbell JD, Mazzilli SA, Beane JE, Kadara H, Lenburg ME, Spira AE, Aberle DR, Krysan K, Dubinett SM. PMID: 37477508; PMCID: PMC10544016.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity. J Immunother Cancer. 2023 09; 11(9). Salehi-Rad R, Lim RJ, Du Y, Tran LM, Li R, Ong SL, Ling Huang Z, Dumitras C, Zhang T, Park SJ, Crosson W, Kahangi B, Abascal J, Seet C, Oh M, Shabihkhani M, Paul M, Krysan K, Lisberg AE, Garon EB, Liu B, Dubinett SM. PMID: 37730274; PMCID: PMC10510892.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    11. Eosinophil recovery in hospitalized COVID-19 patients is associated with lower rates of ICU admission and in-hospital mortality: An observational cohort analysis. Respir Med Res. 2023 Nov; 84:101031. Yan PD, Markovic D, Hixson RY, Shover CM, Buhr RG, Salehi-Rad R, LeMaster B, Tashkin DP, Fulcher JA, Barjaktarevic IZ. PMID: 37647739; PMCID: PMC10232929.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients. Cell Rep Med. 2023 06 20; 4(6):101079. Diray-Arce J, Fourati S, Doni Jayavelu N, Patel R, Maguire C, Chang AC, Dandekar R, Qi J, Lee BH, van Zalm P, Schroeder A, Chen E, Konstorum A, Brito A, Gygi JP, Kho A, Chen J, Pawar S, Gonzalez-Reiche AS, Hoch A, Milliren CE, Overton JA, Westendorf K, IMPACC Network, Cairns CB, Rouphael N, Bosinger SE, Kim-Schulze S, Krammer F, Rosen L, Grubaugh ND, van Bakel H, Wilson M, Rajan J, Steen H, Eckalbar W, Cotsapas C, Langelier CR, Levy O, Altman MC, Maecker H, Montgomery RR, Haddad EK, Sekaly RP, Esserman D, Ozonoff A, Becker PM, Augustine AD, Guan L, Peters B, Kleinstein SH. PMID: 37327781; PMCID: PMC10203880.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    13. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. EBioMedicine. 2022 Sep; 83:104208. Ozonoff A, Schaenman J, Jayavelu ND, Milliren CE, Calfee CS, Cairns CB, Kraft M, Baden LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau KC, Davis MM, Hough CL, Messer WB, Higuita NIA, Metcalf JP, Atkinson MA, Brakenridge SC, Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N, IMPACC study group members. PMID: 35952496; PMCID: PMC9359694.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    14. Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern. Med Sci (Basel). 2022 06 22; 10(3). Young TJ, Salehi-Rad R, Ronaghi R, Yanagawa J, Shahrouki P, Villegas BE, Cone B, Fishbein GA, Wallace WD, Abtin F, Barjaktarevic I. PMID: 35893116; PMCID: PMC9326548.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer. Cancers (Basel). 2021 Jul 18; 13(14). Saggese P, Martinez CA, Tran LM, Lim R, Dumitras C, Grogan T, Elashoff D, Ramin SR, Dubinett SM, Liu B, Scafoglio C. PMID: 34298808; PMCID: PMC8307650.
      View in: PubMed   Mentions: 1  
    16. Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer. Cancer Res. 2021 06 15; 81(12):3295-3308. Li R, Salehi-Rad R, Crosson W, Momcilovic M, Lim RJ, Ong SL, Huang ZL, Zhang T, Abascal J, Dumitras C, Jing Z, Park SJ, Krysan K, Shackelford DB, Tran LM, Liu B, Dubinett SM. PMID: 33853830; PMCID: PMC8776246.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    17. Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden. Cancer Immunol Immunother. 2021 Aug; 70(8):2389-2400. Salehi-Rad R, Li R, Tran LM, Lim RJ, Abascal J, Momcilovic M, Park SJ, Ong SL, Shabihkhani M, Huang ZL, Paul M, Shackelford DB, Krysan K, Liu B, Dubinett SM. PMID: 33507343; PMCID: PMC8289771.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    18. Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa424. Schwab K, Hamidi S, Chung A, Lim RJ, Khanlou N, Hoesterey D, Dumitras C, Adeyiga OB, Phan-Tang M, Wang TS, Saggar R, Goldstein J, Belperio JA, Dubinett SM, Kim JT, Salehi-Rad R. PMID: 33204749; PMCID: PMC7543619.
      View in: PubMed   Mentions: 4  
    19. The Biology of Lung Cancer: Development of More Effective Methods for Prevention, Diagnosis, and Treatment. Clin Chest Med. 2020 03; 41(1):25-38. Salehi-Rad R, Li R, Paul MK, Dubinett SM, Liu B. PMID: 32008627.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    20. Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci Rep. 2020 01 15; 10(1):377. Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ, Huang ZL, Walser TC, Heinrich EL, Lee G, Salehi-Rad R, Crosson WP, Pagano PC, Paul MK, Xu S, Herschman H, Krysan K, Dubinett S. PMID: 31941995; PMCID: PMC6962381.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    21. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy. Cancer Res. 2019 Oct 01; 79(19):5022-5033. Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle DR, Spira AE, Elashoff DA, Wallace WD, Fishbein MC, Dubinett SM. PMID: 31142513; PMCID: PMC6774823.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    22. Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema. J Thorac Dis. 2019 Feb; 11(2):382-385. Salehi-Rad R, Dubinett SM. PMID: 30962980; PMCID: PMC6409254.
      View in: PubMed   Mentions: 3  
    23. Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018 10 01; 198(7):835-837. Salehi-Rad R, Dubinett SM. PMID: 29589957.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    24. Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer. Sci Rep. 2018 06 13; 8(1):9032. Chattopadhyay A, Yang X, Mukherjee P, Sulaiman D, Fogelman HR, Grijalva V, Dubinett S, Wasler TC, Paul MK, Salehi-Rad R, Mack JJ, Iruela-Arispe ML, Navab M, Fogelman AM, Reddy ST. PMID: 29899427; PMCID: PMC5998131.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    25. Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration. Clin Cancer Res. 2017 Aug 15; 23(16):4556-4568. Lee JM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, Tumeh PC, Abtin F, Suh R, Reckamp KL, Lee G, Wallace WD, Lee S, Zeng G, Elashoff DA, Sharma S, Dubinett SM. PMID: 28468947; PMCID: PMC5599263.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCellsCTClinical Trials
    26. Dipyrone approach toward the synthesis of the cytotoxic natural product auripyrone A. Tetrahedron letters. 2010; 38(51):4931-4933. Jung ME, Salehi-Rad R. View Publication.
    27. Total synthesis of auripyrone B using a non-aldol aldol-cuprate opening process. Org Lett. 2010 Jun 18; 12(12):2872-5. Jung ME, Chaumontet M, Salehi-Rad R. PMID: 20499854; PMCID: PMC4099051.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    28. Total synthesis of auripyrone A using a tandem non-aldol aldol/Paterson aldol process as a key step. Angew Chem Int Ed Engl. 2009; 48(46):8766-9. Jung ME, Salehi-Rad R. PMID: 19824033; PMCID: PMC3523744.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    Ramin's Networks
    Concepts (105)
    Derived automatically from this person's publications.
    _
    Co-Authors (48)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _